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Marine sponges are found to be a wide source of bioactive compounds with different effects such as anti-inflammatory or anticancer actions among others. Cyclophilin A (Cyp A) is a target protein implicated in the mechanism of action of immunosuppressive compounds such as Cyclosporine A (CsA). In the present paper we studied the binding between 4 Spongionella compounds (Gracilins H, A, L and Tetrahydroaplysulphurin-1) and Cyp A immobilized over a CM5 sensor chip. Thus, we found that Spongionella compounds showed to have similar binding affinities than CsA with dissociation equilibrium constant in the µM range. Next, the effect of these Spongionella isolated compounds was tested over calcineurin phosphatase activity. The same than CsA, Gracilin H, A and Tetrahydroaplysulphurin-1 were able to inhibit phosphatase activity once the complex between Cyp A-CsA/Spongionella compounds was formed. The ability to avoid the dephosphorylation of NFATc1 was also checked in human T cells isolated from peripheral blood. First, cells were pre-treated with Spongionella compounds or CsA following by Concanavalin A (Con A) stimulation. In these conditions nuclear NFATc1 levels were diminished either by CsA or Gracilin A, L, and Tetrahydroaplysulphurin-1 treatment. Moreover, as happens with CsA due to the inhibition of NFATc1, Interleukine-2 (IL-2) released to the culture medium was significantly decreased with all Spongionella compounds. Results conclude that, Spongionella derivatives preserve T lymphocytes from activation modulating the same pathway than CsA. Thus, this mechanism of action suggests that these compounds could be interesting candidates in drug development as immunosuppressive or anti-inflammatory drugs.





Currently, different natural products have become an important source of bioactive compounds with a wide range of useful properties. Marine sponges are multicellular invertebrates, from the phylum Porifera []. They are dated back 800 million years, however due to their ability to adapt to environmental changes and competitiveness with the biota present they have wide distribution and were able to survive up until our days []. These organisms have risen for a long time the attention of pharmacological industries due to their ability to produce a wide variety of bioactive compounds  ADDIN EN.CITE []. Because of their interesting structures, they can have the key for the treatment of many important diseases. Some of these molecules have been described as anticancer, anti-inflammatory, antiviral, immunosuppressive and antidiabetic compounds  ADDIN EN.CITE []. The order Dendroceratida can be divided into two important families, Darwinellidae and Dictyodendrillidae. Focussing in the family Dictyodendrillidae there is an important genus Spongionella. Thus, different bioactive diterpene compounds were isolated from the marine Mediterranean dendroceratid sponge Spongionella gracilis []. The first reported example of a spongian diterpene isolated from this sponge was Gracilin A, a norditerpene acetate compound []. Moreover, other compounds, specifically the rare classes of bisnorditerpenes such as Gracilin H, the 12-hidroxi-derivative compound Gracilin L and the Tetrahydroaplysulphurin-1 were isolated afterwards. All these Gracilins isolated from the genus Spongionella have the rare structure diacetoxyhexahydrodifuro [2,3-b; 3,2-d] furan 2-one moiety in their molecule  ADDIN EN.CITE []. Gracilin A was reported to be a potent phospholipase A2 inhibitor with the 69% inactivation efficiency []. The diterpenoid compounds were recently described as protective in mouse cortical neurons against oxidative stress, with a relevant neuroprotective effect at mitochondrial function levels. Moreover, mitochondrial parameters related with mitochondrial scope such as membrane potential, caspase 3 inhibition, glutathione levels, an important antioxidant mitochondrial system of protection, and the induction of nuclear factor E2-related factor 2 (Nrf2) translocation to the nucleus were also tested with promising results  ADDIN EN.CITE []. In addition, after Gracilins treatment, both in vitro and in vivo, important modulations of Alzheimer’s hallmarks as ß-secretase, Amyloid-ß42, tau hyperphosphorylation have been reported  ADDIN EN.CITE []. Besides, some of these compounds were able to modulate calcium entrance through Store Operated Calcium Channels and avoid Mitochondrial Permeability Transition Pore (mPTP) opening. Moreover, some of them bind to mitochondrial cyclophilin (Cyp) D, a mitochondrial matrix protein related with the modulation of mPTP []. This last bioactive effect opens a wide field of study of Spongionella compounds over the immunophilin family. In this sense, Cyclophilins (Cyps) have different locations, functions, properties and implications in different physiological and pathological processes  ADDIN EN.CITE []. The subfamily of Cyp A was discovered in bovine thymocites in 1984. Initially this subfamily was described as cytosolic protein which binds to the immunosuppressive compound Cyclosporine A (CsA), the main drug closely related with Cyps  ADDIN EN.CITE []. This cyclic undecapeptide was introduced in human kidney transplantation in the late 1980s. This is a crucial drug component used in immunosuppressive therapies after organ transplantation improving graft survival  ADDIN EN.CITE []. The association CsA-Cyp A produces the inhibition of signal transduction pathways in T lymphocytes. In normal conditions, Cyp A interacts with calcineurin and activates its phosphatase activity, causing interleukin 2 (IL-2) release. Therefore, when CsA is present this activity is inhibited and IL-2 release is blocked  ADDIN EN.CITE []. CsA has shown different affinities for the immunophilins located in distinct intracellular compartments  ADDIN EN.CITE []. As it was mentioned, similar effects were described for CsA and Gracilins at mitochondrial level and Gracilin L and Tetrahydroaplysulphurin-1, in the same way than CsA, have shown high affinity by mitochondrial Cyp D; therefore the aim of this work was to study the effect of Spongionella compounds over the most abundant protein included in the immunophilin family, Cyp A, and the pathways related with this effect in human fresh T lymphocytes. 


2. Material and Methods
2.1 Source of Natural Compounds
The library of compounds was provided by the Marine Biodiscovery Centre (Department of Chemistry, University of Aberdeen), from which four secondary metabolites of Spongionella sp.; Gracilin H, A, L and Tetrahydroaplysulphurin-1 were chosen to develop our experiments. Compounds were purified from their sponge sources, which were freeze- dried, extracted with MeOH and MeOH/CH2Cl2 to obtain the crude extract. The crude extract of each organism was dissolved in H2O and passed through Diaion HP20 resin and re-concentrated under vacuum to obtain a salt-free extract. This extract was subjected to multiple steps of liquid/liquid fractionation, SiO2, Sephadex LH-20 and RP-C18 chromatography to obtain a purity  98%. The structure elucidation of these compounds was based on their High-resolution electrospray ionisation mass spectrometry analysis as well as direct comparison with the previously reported Nuclear Magnetic Resonance spectral data  ADDIN EN.CITE []. 
2.2 Chemicals and Solutions
Carboxymethyl dextran (CM5) sensor chips, Hank’s Balance Solution Surfactant P20 (HBS-EP) buffer (pH 7.4, 0.01 M 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 0.15 M NaCl, 3 mM EDTA, 0.005% polysorbate), amine coupling kit (1-ethyl-3- (3-dimetylaminopropyl) carbodiimide hydrochloride (EDC) and N-hydroxysuccinimide (NHS) were supplied by BiacoreAB (Uppsala, Sweden). Percoll was obtained from Pharmacia (Uppsala, Sweden). Plastic tissue-culture dishes were purchased from Falcon (Madrid, Spain). RPMI and Foetal calf serum (FBS) were bought from Gibco (Glasgow, UK). The Pan T cell Isolation Kit  (human) and the monoclonal antibody to human CD3, clone BW264/56, FITC were purchased from Miltenyi Biotec (Germany). Human IL-2 ELISA kit was obtained from Invitrogen. Active human Cyp A full-length protein, mouse monoclonal [AT1C3] to NFAT2 and lamin B1 were from Abcam. Polyvinylidene fluoride (PVDF) membrane was from Millipore (Temecula). Polyacrylamide gels and molecular weight marker Precision Plus Protein Standards Kaleidoscope were from Bio-Rad (Barcelona, Spain). Protease Inhibitor Complete Tablets and Phosphatase Inhibitor Cocktail Tablets were from Roche (Spain). CsA (purity  98.5%) and rest of Chemicals and reagents were obtained from Sigma-Aldrich (Madrid, Spain). The composition of saline solution (PBS) used for human T lymphocytes purification was in (mM): 137 ClNa, 8.2 Na2HPO4, 1.5 KH2PO4, 3.2 KCl and 2 EDTA. The composition of Umbreit saline solution was in (mM): NaCl 119, Mg (SO4) 1.2, NaH2PO4 1.2, NaHCO3 22.85, KCl 5.94, CaCl2 1. Glucose 1g/L was added to the medium. The pH was equilibrated between 7.2-7.3. Stock solutions of drugs were done in dimethilsulphoxide (DMSO). 
2.3 Human T lymphocytes isolation
Peripheral lymphocytes were isolated from human fresh heparinised blood from healthy volunteers as previously described []. The blood was diluted in the same proportion with PBS plus EDTA 2 mM previously equilibrated at room temperature. 4 mL of diluted blood were placed over 3 mL of isotonic percoll (57,5%) carefully avoiding the mixture of this two phases. Once the tubes were prepared they were centrifuged at 3000 rpm, 25 min at room temperature. After centrifugation, different phases were obtained and only the fraction that contained the population of lymphocytes was collected and washed three times with PBS-EDTA to removed percoll at 1500 rpm, 10 min, room temperature. Lymphocyte purity was always higher than 80%. T lymphocytes were purified from this population with a Pan T cell Isolation Kit. This is an indirect magnetic labelling system for the isolation of untouched T cells. T cell purity was always higher than 95%. Assessment of cell purity was performed by flow cytometry by using a monoclonal antibody to human CD3 labelled with FITC. Viability (>95%) was determined by trypan blue exclusion. Pure T cells were maintained in RPMI 1640 plus 10% FBS and plated in 24 plastic tissue-culture dishes in humidified 5% CO2 and 95% air atmosphere at 37ºC.
2.4 Cells viability measures: MTT assay.
The MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazoliumbromide) assay was used to analyze cell viability as previously described []. Human T lymphocytes were cultured in 24 well plates at the concentration of 2.5x106 cells mL-1 and exposed to different compound concentrations (0.1, 1 and 5 µM) added to the culture medium. Human T cells were maintained in the presence of the pure compound at 37ºC in humidified 5% CO2/95% air atmosphere for 48h. Saponin was used as cellular death control and its absorbance was subtracted from the other data. After incubation the cells were centrifuged (1500 r.p.m., 5 min, 4ºC) and the supernatants was conserved for LDH assays. The pellets were resuspended in saline solution with MTT (250 µg/mL) and then incubated at 37ºC during 30 min. After washing off MTT excess twice with saline solution, cells were disaggregated with H2O and sonicated for 1 minute. Then the absorbance of the colored formazan salt formed was measured at 595 nm in a spectrophotometer plate reader.
2.5 Cells viability measures: LDH release assay.
In addition to MTT assays, the in vitro Toxicology Assay Kit (TOX7, Sigma) was used for measuring lactate dehydrogenase (LDH) release, following the commercial protocol. LDH release was measured in the supernatant obtained after cellular centrifugation (1500 r.p.m., 5 min, 4ºC), before MTT assays. The LDH released to the culture medium was used as an indicator of cell integrity and therefore of cell survival.
2.6 Binding experiments: Surface activation, Ligand Immobilization and Binding
A Biacore X SPR biosensor with Control Software and BIAevaluation software version 3.0 from Biacore (GE Healthcare, Uppsala, Sweden) was used to check the binding between molecules. Sensor surface activation and ligand immobilization were performed by using HBS-EP as running buffer at a flow rate of 5 μL min−1 and 25°C. CM5 sensor chips were used as surface where Cyp A was immobilized as ligand. The CM5 chip is a glass slide coated with a thin layer of gold with a matrix of carboxymethylated dextran covalently attached. The CM5 chip was activated using an amine coupling kit. Following manufacture instructions, a mixture (1:1, v/v) of EDC and NHS was applied for 2 min over the sensor chip. After activation, the ligand, 100 μg/mL of active human Cyp A protein dissolved in sodium acetate 10 mM at pH 4.5 or 6 was added to be immobilized over a CM5 sensor chip. Finally ethanolamine-HCl was injected to deactivate the remaining active esters. Next, analytes were added to check the binding between them and Cyp A. Once analytes were tested and interaction was observed, individual binding curves were analyzed by determining the kinetic constants of analytes-Cyp A binding, namely, the observed rate constant (Kobs), the association rate constant (Kass), the dissociation rate constant (Kdiss), and the kinetic equilibrium dissociation constant (KD). At equilibrium, by definition, Kdiss/Kass= KD. The pseudo-first-order association rate constants Kobs (s-1) were determined for each compound concentration by using the 1:1 Langmuir association model of BiaEvaluation software (BiaCore, Uppsala, Sweden). Then a representation of Kobs against the corresponding concentration of each compound was done. These plots follow a linear correlation coefficient. From the equation of these representations, Kass, M-1 s-1, gradient of the Plot, and Kdiss, s -1, intercept of the plot was obtained. Within these two values, the kinetic equilibrium dissociation constant KD for each analyte-Cyp A binding was obtained.  
The duration of the sample injection was 2 min at 10μL min−1 flow rate. Next, dissociation of bounded molecules in HBS-EP buffer flow was studied. The bounded drugs were removed from the chip surface before the next injection by adding 1 M Glycine-HCl at pH 2.5 for 1 min. The association phase was used to quantify the compound-Cyp A interactions.
2.7 Interleukin 2 release
Human T lymphocytes at the concentration of 1x106 cells mL-1 were plated in 24 well plates and pre-treated for 2 hours with Spongionella compounds (1 µM). Then, cells were stimulated with Concanavalin A (Con A) at 50µg/mL for 48 h to induce IL-2 release. The amount of IL-2 released to the culture medium was evaluated using Human IL-2 ELISA kit.
2.8 Calcineurin Phosphatase Activity assay
Calcineurin phosphatase activity was used as a measure of Cyp A activity. In this way the calcineurin Phosphatase Assay Kit (Enzo Life Sciences, Inc., Farmingdale, NY) was employed. This is a complete colorimetric assay kit for measuring calcineurin phosphatase activity. The Cyp-A-drug complex was allowed to form for 1h at room temperature. 1 nM of Cyp A and different concentrations of drugs were employed dissolved in deionised water. After 1h recombinant calmodulin (0.25 µM) and recombinant calcineurin (40 units per well) were added to the complex formed between Cyp A and different Spongionella compounds or CsA. The complex were incubated for 30 min. Next, RII phosphopeptide substrate was added at final concentration of 0.15 mM allowing the development of the reaction for 1h at room temperature. Then 100µL of development reagent was added and incubated for 20 min at room temperature. Finally, the A620 of the 96-well plate samples was measured using Multi- Mode Microplate Reader Synergy TM 4 from Biotek (Winooski, VT, USA).
2.9 Western Blotting
Cells were incubated first with Spongionella compounds or CsA for 2 h after which Con A (50µg/mL) was added for 48 h. After incubation, T cells were centrifuged and washed twice with ice-cold saline solution (Umbreit) at 1500 rpm, 5 min and 4ºC. Then, the pellet was resuspended in 50µL of hypotonic lysis buffer solution to extract cytosolic proteins for 15 min with the following composition mM: 20 Tris-HCl, 10 NaCl and 3 MgCl2 containing 10X phosphatase inhibitors and 7X protease inhibitor. Cells were pelleted at 3000 rpm, 10 min and 4ºC to removed cytosolic protein fraction. The supernatant was collected and pellet obtained was resuspended in 30µL of nuclear lysis buffer composed by: 100 mM Tris, 2 mM NaVO4, 10 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM NaF, 20 mM Na4P2O7, 1% Triton-X-100, 10% Glycerol, 0,1% SDS and 0,5% Deoxychocolate Sodium containing 1 mM PMSF and 10X protease inhibitor cocktail for 30 min vortexing every 10 min. Samples were then centrifuged at 14000g at 4ºC for 30 min. The supernatants of interest were collected as protein nuclear fraction. The determination of protein concentration was done using Direct Detect (Millipore) and BSA as standard protein. Samples of cell lysates containing 10µg of nuclear fraction of total protein were used for electrophoresis. Samples for electrophoresis were dissolved in a 15-20% polyacrylmide gel and blotted to PVDF membrane by reduced SDS-PAGE. To determine the protein size and also to monitor the progress of electrophoresis run, Precision Plus Protein Standards Kaleidoscope molecular weight marker was used. Then, membranes were blocked with 0,5% BSA in washing buffer (PBS+0.1% Tween) and incubated 10 min with primary antibody anti-NFAT2 (1:1000). After three washes with washing buffer (PBS+0.1% Tween 20), membranes were incubated with the secondary antibody anti-Mouse IgG conjugated with horseradish peroxidase. The immunoreactive bands were detected using the Supersignal West Pico or Supersignal West Femto Maximum Sensitivity Substrate (Pierce) and the Diversity GeneSnap software (Syngene). NFAT2 signal was normalized using Lamin B1 (1:1000).
2.10 Statistical analysis




Cyp A is a ubiquitously distributed protein that belongs to the immunophilin family []. Since Spongionella-isolated compounds had showed affinity by mitochondrial Cyp D in the same way than CsA, the affinity of these compounds by Cyp A was checked by using a highly sensitive biosensor Biacore X. Cyp A, the ligand, was attached to the sensor surface and compounds in solution were used as ligate. First, Cyp A was immobilized over a CM5 sensor chip previously activated  ADDIN EN.CITE [, ]. 100µg mL-1 of human Cyp A dissolved in sodium acetate (pH 4.5) were added to the sensor chip by introducing an active disulphide group onto the sensor chip surface, Figure 1A. In these conditions, a typical covalent binding curve was obtained. Then, the CM5 chip surface was washed with HBS buffer and no fall in the signal was observed, indicating Cyp A immobilization onto the sensor chip surface. Finally ethanolamine-HCl was injected to deactivate reactive disulphides excess, remove non-covalently bound protein and avoid non-specific binding. Next, CsA was used as control of binding to check the affinity of immobilized Cyp A. As Figure 1B shows, when different concentrations of CsA were added over immobilized Cyp A, typical association curves profiles were obtained. In the presence of 5µM of CsA the signal was 25.4 RU, while in the presence of 40µM of CsA the response reaches 74 RU. Individual binding curves from Figure 1B were analyzed as described in material and methods and Kobs for each concentration of CsA was obtained. When Kobs was represented against each CsA concentration, Figure 1C, a linear regression with a correlation coefficient of r= 0.999 was obtained. From this representation, Kass, M-1 s-1, slope, and Kdiss, s -1, Y-intercept, were obtained. Within these two values, the kinetic equilibrium dissociation constant KD  (Y-intercept/slope) for the CsA-Cyp A association was obtained. The value of this constant was 6.83x10-6  1.1x10-6 M CsA. 
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Table 1: Kinetic equilibrium dissociation constant (KD) values for the binding Cyp A-CsA and Spongionella isolated compounds obtained in the biosensor after Cyp A immobilization in buffers at pH 4.5 or pH 6. Mean ± SEM of 4 experiments.

It has been described that the formation of the complex between CsA and Cyp A inhibits calcineurin phosphatase activity  ADDIN EN.CITE [, ]. Therefore calcineurin phosphatase activity was checked in the presence of Spongionella compounds. In this case, a concentration close to the KD was used. When Cyp A was incubated in the presence of 6µM CsA a significant 28.33%  3.07 (p < 0.01) reduction in calcineurin phosphatase activity was observed. In the presence of 15 and 3µM of Gracilin H and A respectively, significant inhibitions of 13.54%  2.80 (p < 0.05) and 13.25%  5.29 (p < 0.05) were observed. The highest reduction, 24.71%  0.49 (p < 0.01) was obtained in the presence of 6µM Tetrahydroaplysulphurin-1. However, Gracilin L did not show any effect over calcineurin phosphatase activity. When compounds were added in the absence of Cyp A no effects were observed over calcineurin phosphatase activity.
The nuclear factor of activated-T cells 1 (NFATc1) is highly expressed in peripheral T lymphocytes and the stimulation of these cells with Con A produces NFATc1 translocation from the cytosol to the nucleus  ADDIN EN.CITE [, ]. In this sense, the inhibition of calcineurin blocks the dephosphorilation of multiple phosphoserines on NFATc1 avoiding the translocation and the subsequent activation of T cells  ADDIN EN.CITE []. Therefore, the nuclear expression of NFATc1 in human peripheral T lymphocytes in the presence of Spongionella compounds was next checked. To develop these experiments, the viability and integrity of T cells after Spongionella isolated compounds incubation was first evaluated. In this way two parameters were measured, mitochondrial activity with the MTT assay and LDH release. Spongionella isolated compounds showed no cytotoxic effect over human fresh T lymphocytes at concentrations between 0.1 to 5µM after 48 h incubation, while a 37.88%  9.81 (p<0.05) decrease in mitochondrial activity was observed after CsA incubation (5µM). However, in all these experiments there was no release of LDH to the culture medium indicating that cellular integrity is maintained (data not shown). From these results, 1µM and 0.2µM for Spongionella compounds and CsA respectively were chosen to study NFATc1 expression in T cells after Con A activation. As Figure 3 shows, cells stimulated with Con A for 48h exhibits a 76.28%  1.17 (p < 0.001) increase in the intensity of NFATc1 band in the nucleus comparing with T cells in resting conditions. This value is considered as 100% of NFATc1 nuclear expression. When cells were treated with CsA, NFATc1 band intensity decreases compared to Con A treated cells near to control cell values (30.93%  0.274, p < 0.01). Gracilin H, did not significantly reduce the expression of NFATc1 in nuclear cell lysates. However, either Gracilin A, L and Tetrahydroaplysulphurin-1 significantly reduce NFATc1 nuclear levels. Gracilin A and L reduce 61% and 65% respectively the expression of NFATc1. Again, Tetrahydroaplysulphurin-1 was as effective as CsA reaching the same band intensity than control cells, 23.10%  3.92, p<0.01.
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In this paper the effects of Spongionella compounds and CsA over Cyp A and related pathways are compared. CsA is the main drug used after soft tissue transplantation and to control and treat various human diseases  ADDIN EN.CITE []. The toxicity and the pour solubility of this compound is the major obstacle in the immunosuppressive therapies where it is employed  ADDIN EN.CITE []. Previous works evaluated the cytotoxicity of Spongionella compounds in the human chronic myelogenous leukaemia cells (K562) and in normal peripheral blood mononuclear cells after 24h of incubation. The cytotoxic effects of Spongionella compounds in K562 showed IC50 values range between 0.6 to 4.5µM. In the case of mononuclear cells, natural compounds showed slightly lower toxicity, that is, IC50 values range was between 0.8 to 6.5µM. Only Tetrahydroaplysulphurin-1 showed modest selectivity toward the leukaemia cell line  ADDIN EN.CITE []. However, in mouse cortical neurons Spongionella compounds did not show signs of cytotoxicity even at the highest concentration tested (1µM), on the contrary they showed neuroprotective effects  ADDIN EN.CITE []. In the same way, in T cells, no cytotoxic effects were observed after 48h of incubation at the concentration up to 5µM. Therefore from all these results Spongionella compounds seem to induce lower toxicity than CsA. The mechanism of action through CsA exerts the immunosuppressive action is due to the complex formed with Cyp A and the next blockade of calcineurin phosphatase activity  ADDIN EN.CITE []. Moreover, CsA has affinity also for other immunophilins such as Cyp D among others. In this study we assessed the possible effect of Spongionella isolated compounds as immunosuppressive agents due to the findings showed in previous work that demonstrated that Spongionella compounds, as well as CsA, bound to Cyp D []. From these results, all Spongionella compounds showed different binding affinities for Cyp A. Comparing with the affinity of CsA by Cyp A, Gracilin A and Tetrahydroaplysulphurin-1 showed 2.69 and 1.33 times higher affinity than CsA, while Gracilin H and L had lower affinity. It has been described that Cyp A-CsA association depends on the pH of the immobilization buffer of the protein, being optimal at pH 6  ADDIN EN.CITE []. Therefore the effect of pH was also checked with Spongionella compounds. The first observation with these experiments was that the amount of immobilized Cyp A is independent of the pH of buffer, however the association with compounds is totally different. When pH 6 buffer is used for Cyp A immobilization, Spongionella compounds did not show affinity for the protein, while the affinity of CsA was highly increased. It seems that depending on the pH for Cyp A immobilization; the active sites of the protein that interact with CsA can be more or less accessible. It has been described that under low pH (pH 4.5) the surface charge potential of Cyp A seems to force the molecule to orient itself with the CsA binding surface positioned less accessible toward the activated chip surface. Within this orientation many covalent linkages would occur resulting in the possibility of steric occlusion of the binding of CsA and therefore lower affinity  ADDIN EN.CITE []. In the case of Spongionella compounds, when the immobilization is done at pH 6 no interactions were detected. Therefore, the absence of binding in these conditions is probably due to orientation that the protein has on the sensor surface at this pH. Thus, Spongionella compounds and CsA are probably sharing part of the Cyp A pocket binding that is slightly modified depending on the immobilization pH and due to this, the affinities changes. In this sense, the mechanism of action of immunosuppressive drugs consists on occupying the proline isomerisation areas on Cyp A  ADDIN EN.CITE [, , ]. 
As it was mentioned, at pH 4.5, the affinity by Cyp A was different depending on the Spongionella compound tested. Based only on the structure of these compounds it is difficult to conclude the higher affinity observed with Gracilin A and Tetrahydroaplysulphurin-1. The lower affinity sowed by Gracilin L could be due to the presence of a hydroxyl group in position 3 that produce a steric impediment or a repulsive effect of this group. In the case of Gracilin H, the structure is totally different and maybe the oxygen position in the heterocyclics on this part of the molecule produces lower affinity. It is well known that most of the potent inhibitors, small molecules, described until now contained an amide fragment that contributes to the inhibitory activity via forming 2-3 hydrogen bonds with residues Arg55, Gln63 and Asn102 around the “saddle” between the two sub-binding pockets of Cyp A (site A and site B) []. This can be also the case of Spongionella compounds. In any case, since the molecule disposition seems to be critical for the interactions, a further study of structure/activity relation will be done.
Once the complex CsA-Cyp A is constituted, the binding between the cytosolic Cyp A and calcineurin is blocked  ADDIN EN.CITE [, , ]. In our experiments, we demonstrate that with the exception of Gracilin L, that did not show a significant inhibition, the rest of Spongionella compounds also inhibit calcineurin phosphatase activity in the same way than CsA  ADDIN EN.CITE [, ]. This effect is related to Cyp A since the inhibitory effect is observed only in the presence of the protein. The inhibition of calcineurin phosphatase activity implies that NFATc1 stays in the phosphorylated state in the cytosol. In normal conditions, the dephosphorylation of NFATc1 will allow the translocation to the nucleus where the transcription of genes encoding pro-inflammatory cytokines, such as IL-2, should start  ADDIN EN.CITE [, ]. In this sense, it is well known that lectins are T cell mitogen-inducing IL-2 production. For this reason, we employed Con A to induced T-cell activation and IL-2 production  ADDIN EN.CITE [, ]. The activation is a complex process that involves transcriptional factors that leads in the transcriptional activation different genes. As it was mentioned, among others, the NFAT family is one of the most relevant modulating pro-inflammatory genes that encode IL-2 []. In cells stimulated with Con A but pre-treated with CsA, NFATc1 nuclear band intensity was efficiently reduced comparing with Con A treated cells. In this way, CsA was earlier described to have good efficacy avoiding the dephosphorylation of NFATc1  ADDIN EN.CITE [, ]. After this blockade, IL-2 production was inhibited. Once NFATc1 is translocated to the nucleus, it binds to DNA structure and starts the genes transcription that encodes pro-inflammatory cytokines where among others IL-2 is produced. CsA was described to reduce IL-2 production  ADDIN EN.CITE []. From our results, we point out this effect as a result of the complex formed with Cyp A. The same as CsA, Spongionella compounds were able to inhibit NFATc1-traslocation, being Tetrahydroaplysulphurin-1 the most active compound and Gracilin H the less. This activities range could be related with the Cyp A affinity and also with the effect of compounds over cytosolic calcium levels []. NFAT is a protein family calcium-sensitive  ADDIN EN.CITE []. In T cells, NFAT localization is related with SOC influx  ADDIN EN.CITE [, ]. In this sense, Tetrahydroaplysulphurin-1, Gracilin A and L were able to inhibit SOC entry while Gracilin H did not have this effect []. In fact, the lower affinity of Gracilin L by Cyp A can be compensated by the strong inhibition in SOC influx observed. However, Gracilin H shows low affinity by Cyp A and did not modify SOC entry. Thus, we point out that Gracilin L blocks NFATc1 translocation mainly due to the regulation of calcium signalling through SOC channels while Tetrahydroaplysulphurin-1 and Gracilin A, as well as CsA, exert its action manly over calcineurin, although SOC inhibition is also related.
All Spongionella compounds showed to reduce IL-2 production efficiently. In the case of Tetrahydroaplysulphurin-1, IL-2 production was inhibited with similar efficiency than CsA, while again Gracilin H showed to inhibit the production of IL-2 with the lowest potency. 
Regarding the correlation between affinity of compounds by Cyp A, the effect over NFATc1 inhibition in activated T-cells and the inhibition of IL-2 production, only in the case of Tetrahydroaplysulphurin-1 the three parameters take place. In this case, NFATc1 inhibition and IL-2 reduction are in accordance with the high affinity showed in the biosensor, therefore high affinity for Cyp A correlates with its biological effect. These differences between the affinity of Cyp A and Spongionella isolated compounds and the effect in IL-2 reduction and NFATc1 translocation can be explained as changes in the conformational flexibility of the protein once it is immobilized over the sensor chip  ADDIN EN.CITE []. These conformational changes can affect the binding and as consequence different affinities are observed while the biological activity is quite similar. It is important to bear in mind that the affinity quantified in the biosensor is not always comparable with an efficient biological effect. In fact, good affinities for binding to Cyp A in the case of different CsA analogous were not always directly related with effective biological effects []. Thus, in the case of Gracilin A and Tetrahydroaplysulphurin-1 a similar mechanism of action than CsA is suggested. Nevertheless, all compounds were able to reduced IL-2 production on Con A-stimulated T lymphocytes. In the case of Gracilin H and L, in addition to Cyp A binding, we point to another additional mechanism as the modulation of calcium signalling or other target implicated in the modulation of immune response  ADDIN EN.CITE []. In this way, all Spongionella compounds could be promising tools in the treatment of immune disorders and chronic inflammation. CsA immunosuppressive therapies are associated with hepatotoxicity and neurotoxicity  ADDIN EN.CITE []. These side effects are related with the generation of reactive oxygen species  (ROS) and lipid peroxidation []. Moreover, previous studies showed that Spongionella compounds had protective effects in mouse cortical neurons improving mitochondrial functioning by inhibiting ROS production and increasing antioxidant enzyme levels  ADDIN EN.CITE []. Thus, Spongionella compounds can be good starting points for improving immunosuppressive therapies eliminating the adverse effects of CsA. In addition, the low molecular size of Spongionella compounds comparing with CsA could also improve the variability that has CsA in intestinal absorption that makes difficult to establish a good concentration-effect to decrease the toxicity in immunosuppressive therapies  ADDIN EN.CITE []. Moreover, considering the lack of toxicity over T cells and in in-vivo experiments in an Alzheimer disease mouse model, and the specificity showed by Gracilin H and Gracilin A for binding to Cyp A make Spongionella compounds attractive as a possible alternative for using in immunosuppressive therapies  ADDIN EN.CITE [].

Conclusions
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Figure 1.  CM5 dextran chip activation, Protein immobilization and CsA association curves and ligand binding analysis. A. Activation: first arrow indicates the addition of EDC/NHS to activate CM5 dextran surface. Immobilization: the second arrow indicates the addition of 100µg mL-1 of Cyp A. Blocking: The third arrow indicates the blocking of remaining activated sites with ethanolamine/HCl. B. Cyp A-CsA association: association curves after addition of different amounts of CsA to immobilized Cyp A. Different CsA concentrations were injected using HBS-EP as running buffer and flow rate of 10µg mL-1. The association curves were obtained after subtraction of their respective solvent control. C. Analysis of ligand binding: kinetic plot of apparent association rate constant Kobs (s-1) obtained from plot in B (calculated by BiaEvaluation software) versus Cyp A concentration. The graphics are from one experiment representative of 4 experiments.

Figure 2. Spongionella compounds association curves over immobilized Cyp A. Association curves after addition of different concentrations of Spongionella compounds, Gracilin H (A), Gracilin A, (B), Gracilin L (C) and Tetrahydroaplysulphurin-1 (D), over immobilized Cyp A. HBS-EP was used as running buffer at flow rate of 10µg mL-1. The association curves were obtained after subtraction of their respective solvent control. The graphics are from one experiment representative of 4 experiments.

Figure 3. Effect of CsA or Spongionella compounds over NFATc1 nuclear levels in human T lymphocytes activated with Con A. NFATc1 levels were studied as nuclear fraction after 48h incubation with compounds. Human T lymphocytes were pre-treated for 2 h with CsA (0,2µM) or Gracilin H (1µM), Gracilin A (1µM), Gracilin L (1µM) or Tetrahydroaplysulphurin-1 (1µM) and afterward incubated with Con A (50µg mL-1) for 48 h. A: Representative image of one experiment B: Mean of the ratio of the nuclear NFATc1/lamin B1 band intensity. All results are presented as the percentage of NFATc1 in the nucleus and compare the differences between Con A and Con A + CsA or Spongionella compounds by ANOVA statistical analysis followed by post hoc Dunnett’s t test. * (p < 0.05), ** (p < 0.01) or between Con A and control cells ### (p < 0.001). Data are mean  SEM of 4 independent experiments.  
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